Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 18 August 1989:
Vol. 245. no. 4919, pp. 743 - 746
DOI: 10.1126/science.2549633
Prev | Table of Contents | Next

Articles

Science, Vol 245, Issue 4919, 743-746
Copyright © 1989 by American Association for the Advancement of Science

articles

The MHC-binding and gp120-binding functions of CD4 are separable

D Lamarre, A Ashkenazi, S Fleury, DH Smith, RP Sekaly, and DJ Capon

Laboratoire d'Immunologie, Institut de Recherches Cliniques de Montreal, Quebec, Canada.

CD4 is a cell surface glycoprotein that is thought to interact with nonpolymorphic determinants of class II major histocompatibility (MHC) molecules. CD4 is also the receptor for the human immunodeficiency virus (HIV), binding with high affinity to the HIV-1 envelope glycoprotein, gp120. Homolog-scanning mutagenesis was used to identify CD4 regions that are important in class II MHC binding and to determine whether the gp120 and class II MHC binding sites of CD4 are related. Class II MHC binding was abolished by mutations in each of the first three immunoglobulin-like domains of CD4. The gp120 binding could be abolished without affecting class II MHC binding and vice versa, although at least one mutation examined reduced both functions significantly. These findings indicate that, while there may be overlap between the gp120 and class II MHC binding sites of CD4, these sites are distinct and can be separated. Thus it should be possible to design CD4 analogs that can block HIV infectivity but intrinsically lack the ability to affect the normal immune response by binding to class II MHC molecules.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.
A. Thedrez, C. de Lalla, S. Allain, L. Zaccagnino, S. Sidobre, C. Garavaglia, G. Borsellino, P. Dellabona, M. Bonneville, E. Scotet, et al. (2007)
Blood 110, 251-258
   Abstract »    Full Text »    PDF »
Evidence for a Domain-Swapped CD4 Dimer as the Coreceptor for Binding to Class II MHC..
A. Maekawa, B. Schmidt, B. Fazekas de St. Groth, Y.-H. Sanejouand, and P. J. Hogg (2006)
J. Immunol. 176, 6873-6878
   Abstract »    Full Text »    PDF »
CD4 Dimers Constitute the Functional Component Required for T Cell Activation.
M.-C. Moldovan, A. Yachou, K. Levesque, H. Wu, W. A. Hendrickson, E. A. Cohen, and R.-P. Sekaly (2002)
J. Immunol. 169, 6261-6268
   Abstract »    Full Text »    PDF »
Cloning and Modeling of the First Nonmammalian CD4.
R. Koskinen, U. Lamminmaki, C. A. Tregaskes, J. Salomonsen, J. R. Young, and O. Vainio (1999)
J. Immunol. 162, 4115-4121
   Abstract »    Full Text »    PDF »
A Site for CD4 Binding in the {beta}1 Domain of the MHC Class II Protein HLA-DR1.
J. Brogdon, D. D. Eckels, C. Davies, S. White, and C. Doyle (1998)
J. Immunol. 161, 5472-5480
   Abstract »    Full Text »    PDF »
Inhibition of CD4 Translation Mediated by Human Immunodeficiency Virus Type 1 Envelope Protein in a Cell-free System.
S. Bour, R. Geleziunas, and M. A. Wainberg (1997)
J. Biol. Chem. 272, 29005-29014
   Abstract »    Full Text »    PDF »
Mapping of the Primary Binding Site of Measles Virus to Its Receptor CD46.
C. J. Buchholz, D. Koller, P. Devaux, C. Mumenthaler, J. Schneider-Schaulies, W. Braun, D. Gerlier, and R. Cattaneo (1997)
J. Biol. Chem. 272, 22072-22079
   Abstract »    Full Text »    PDF »
Bioactive Peptide Design Based on Protein Surface Epitopes. A CYCLIC HEPTAPEPTIDE MIMICS CD4 DOMAIN 1 CCprime LOOP AND INHIBITS CD4 BIOLOGICAL FUNCTION.
T. Satoh, J. M. Aramini, S. Li, T. M. Friedman, J. Gao, A. E. Edling, R. Townsend, U. Koch, S. Choksi, M. W. Germann, et al. (1997)
J. Biol. Chem. 272, 12175-12180
   Abstract »    Full Text »    PDF »
An HLA-DR1 Transgene Confers Susceptibility to Collagen-induced Arthritis Elicited with Human Type II Collagen.
E. F. Rosloniec, D. D. Brand, L. K. Myers, K. B. Whittington, M. Gumanovskaya, D. M. Zaller, A. Woods, D. M. Altmann, J. M. Stuart, and A. H. Kang (1997)
J. Exp. Med. 185, 1113-1122
   Abstract »    Full Text »    PDF »
A computer screening approach to immunoglobulin superfamily structures and interactions: Discovery of small non-peptidic CD4 inhibitors as novel immunotherapeutics.
S. Li, J. Gao, T. Satoh, T. M. Friedman, A. E. Edling, U. Koch, S. Choksi, X. Han, R. Korngold, and Z. Huang (1997)
PNAS 94, 73-78
   Abstract »    Full Text »    PDF »
Receptors and Transmembrane Signaling.
B.L. Stoddard, H.-P. Biemann, and D.E. Koshland Jr. (1992)
Cold Spring Harb Symp Quant Biol 57, 1-15
   Abstract »    PDF »
Structural Aspects of CD4 and CD8 Involvement in the Cellular Immune Response.
W.A. Hendrickson, P.D. Kwong, D.J. Leahy, S.-E. Ryu, H. Yamaguchi, S. Fleury, and R.-P. Sekaly (1992)
Cold Spring Harb Symp Quant Biol 57, 549-556
   Abstract »    PDF »
Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice.
T. Kion and G. Hoffmann (1991)
Science 253, 1138-1140
   Abstract »    PDF »
Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120.
R. Finberg, D. Diamond, D. Mitchell, Y Rosenstein, G Soman, T. Norman, S. Schreiber, and S. Burakoff (1990)
Science 249, 287-291
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)